These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2360261

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Continuous octreotide infusion for the treatment of secretory diarrhea caused by acute intestinal graft-versus-host disease in a child.
    Beckman RA, Siden R, Yanik GA, Levine JE.
    J Pediatr Hematol Oncol; 2000; 22(4):344-50. PubMed ID: 10959906
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies.
    Ippoliti C, Champlin R, Bugazia N, Przepiorka D, Neumann J, Giralt S, Khouri I, Gajewski J.
    J Clin Oncol; 1997 Nov; 15(11):3350-4. PubMed ID: 9363865
    [Abstract] [Full Text] [Related]

  • 6. Octreotide in the management of diarrhea induced by graft versus host disease.
    Ippoliti C, Neumann J.
    Oncol Nurs Forum; 1998 Jun; 25(5):873-8. PubMed ID: 9644703
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Management of cancer treatment-related diarrhea. Issues and therapeutic strategies.
    Kornblau S, Benson AB, Catalano R, Champlin RE, Engelking C, Field M, Ippoliti C, Lazarus HM, Mitchell E, Rubin J, Stiff PJ, Vokes E, Wadler S.
    J Pain Symptom Manage; 2000 Feb; 19(2):118-29. PubMed ID: 10699539
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Etiology and outcome of diarrhea after marrow transplantation: a prospective study.
    Cox GJ, Matsui SM, Lo RS, Hinds M, Bowden RA, Hackman RC, Meyer WG, Mori M, Tarr PI, Oshiro LS.
    Gastroenterology; 1994 Nov; 107(5):1398-407. PubMed ID: 7926504
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chronic diarrhoea after allogenic bone marrow transplantation.
    Radu B, Allez M, Gornet JM, Lemann M, Socie G, Gluckman E, Zagdanski AM.
    Gut; 2005 Jan; 54(1):161, 174. PubMed ID: 15591522
    [No Abstract] [Full Text] [Related]

  • 19. [The usefulness of the somatostatin analog SMS 201-995 in treating Cryptosporidium-induced diarrhea associated with the acquired immunodeficiency syndrome].
    Santos Gil I, Mur Gimeno P, Herreros Fernández M, del Arco Galán C.
    Med Clin (Barc); 1990 Dec 08; 95(20):796. PubMed ID: 2131392
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.